Why the study?
Do leadless pacemakers reduce the incidence of pacing-induced cardiomyopathy compared to transvenous pacemakers in pacemaker-dependent patients?
Do leadless pacemakers reduce the incidence of pacing-induced cardiomyopathy compared to transvenous pacemakers in pacemaker-dependent patients?
Leadless pacemakers are associated with a significantly lower incidence of pacing-induced cardiomyopathy compared to traditional transvenous pacemakers in pacemaker-dependent patients.
LP may lower PICM risk versus TVP in pacemaker-dependent patients; hypothesis-generating and should not yet change practice.
Incidence of PICM is significantly lower with LP compared with TVP in pacemaker-dependent patients. Age and TVP as pacing modality were predictors for PICM.
No takes yet. Share an insight, caveat, or question.
Sanchez et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: